ClinicalTrials.Veeva

Menu

Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4

The University of Chicago logo

The University of Chicago

Status and phase

Completed
Phase 2

Conditions

Opioid-Related Disorders
Substance-Related Disorders

Treatments

Drug: 0% N2O
Drug: 20% N2O
Drug: 10% N2O
Drug: 40% N2O
Drug: 30% N2O

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT00000252
NIDA-08391-4
R01DA008391 (U.S. NIH Grant/Contract)
R01-08391-4

Details and patient eligibility

About

The purpose of this study is to conduct experiments to examine subjective and reinforcing effects of nitrous oxide. Mood altering and psychomotor effects will be tested on non-drug abusers and preference procedures will be used to assess reinforcing effects. To examine the lack of acute tolerance development to the subjective, cognitive, and psychomotor effects of nitrous oxide in healthy volunteers.

Enrollment

11 patients

Sex

All

Ages

21 to 29 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

11 participants in 5 patient groups

0% N2O
Sham Comparator group
Description:
Subjects will inhale 0% N2O
Treatment:
Drug: 0% N2O
10% N2O
Active Comparator group
Description:
Subjects will inhale 10% N2O
Treatment:
Drug: 10% N2O
20% N2O
Active Comparator group
Description:
Subjects will inhale 20% N2O
Treatment:
Drug: 20% N2O
30% N2O
Active Comparator group
Description:
Subjects will inhale 30% N2O
Treatment:
Drug: 30% N2O
40% N2O
Active Comparator group
Description:
Subjects will inhale 40% N2O
Treatment:
Drug: 40% N2O

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems